Kids’ Cancer Research Foundation adds two researchers to board

Dr. Andras Heczey of Texas Children’s Cancer Center.
Dr. Andras Heczey of Texas Children’s Cancer Center.

Kids’ Cancer Research Foundation recently announced the addition of two pediatric cancer researchers to its medical advisory board.

The San Luis Obispo-based nonprofit group is dedicated to finding new treatments for neuroblastoma, a rare cancer that occurs in children. Kids’ Cancer Research’s new board members both specialize in researching this type of cancer.

Dr. Paul Sondel, a University of Wisconsin-Madison professor of pediatrics, human oncology and medical genetics, has spent the past 40 years of his career developing pediatric cancer treatments, especially those used to fight neuroblastoma.

Dr. Andras Heczey, a physician-scientist at the Texas Children’s Cancer Center and a Baylor College of Medicine assistant professor of pediatric hematology-oncology, has focused his research on using T-cells, a type of white blood cell, to fight tumors.

“These two researchers, along with our other Medical Advisory Board members, are at the very center of how this cutting-edge research is getting us closer to our goals for finding effective treatments ... while having no or very low potential side effects,” said Frank Kalman, Kids’ Cancer Research executive director.